UnitedHealth Group (NYSE: UNH) is set to release its Q1 2024 results on April 16, with revenue expected to reach $99.7 billion and earnings projected at $6.75 per share on an adjusted basis, in line with street expectations. The company is anticipated to benefit from the growing contribution of its Optum Health business, alongside an increase in health insurance memberships.
Investors are closely watching the medical costs in Q1, as management foresees a rise in this metric in the near future. Despite the expected in-line results for Q1, there is room for stock growth from its current levels of under $460.
